O-demethylation of 4-nitroanisole
1037
Lewis , D. F. V. and Lake, B. G., 1995, Molecular modelling of members of the CYP2A subfamily :
application to studies of enzyme speci®city. Xenobiotica, 25, 585±599.
Lowry, O. H., Rosenbrough , N. J., Farr, A. L. and Randall , R. J., 1951, Protein measurement with
the folin phenol reagent. Journal of Biological Chemistry, 193, 265±275.
Nakajima , M., Yamamoto , T., Nunoya , K-I., Yokoi , T., Nagashima , K., Inque , K., Funae, Y.,
Shimada , N., Kamataki , T. and Kuroiwa , Y., 1996, Role of cytochrome P4502A6 in the C-
oxidation of nicotine. Drug Metabolism and Disposition, 24, 1212±1217.
Maurice, M., Emiliani , S., Dalet -Beluche , I., Derancourt , J. and Lange, R., 1991, Isolation and
characterisation of a cytochrome P450 of the IIa subfamily from human liver microsomes.
European Journal of Biochemistry, 200, 511±517.
Meier , U. T., Kronbach , T. and Meyer , U. A., 1985, Assay for mephenytoin metabolism in human
liver microsomes by high performance liquid chromatography. Analytical Biochemistry, 151,
2
86±291.
Neal, J. J. and Wu, D., 1994, Inhibition of insect cytochromes P450 by furanocoumarins. Pesticide
Biochemistry and Physiology, 50, 43±50.
Nelson , D. R., Kamataki , T., Waxman , D. J., Guengerich , F. P., Estabrook , R. W., Feyereisen , R.,
Gonzalez, F. J., Coon , M. J., Gunsalus , I. C., Gotoh , O., Okuda, K. and Nebert , D., 1993,
The P450 superfamily : update. DNA and Cell Biology, 12, 1±51.
Omura , T. and Sato, R., 1964, The carbon monoxide binding pigment of liver microsomes. Journal of
Biological Chemistry, 239, 2370±2378.
Pearce, R., Greenway , D. and Parkinson , A., 1992, Species diåerences and interindividual variation in
liver microsomal cytochrome P450 2A enzymes: eåects on coumarin, dicumarol and testosterone
oxidation. Archives of Biochemistry and Biophysics, 298, 211±225.
Reigh , G., McMahon , H., Ishizaki , M., Ohara, T., Shimae , K., Esumi , Y., Green , C., Tyson , C. and
Ninomiya , S.-I., 1996, Cytochrome P450 species involved in the metabolism of quinoline.
Carcinogenesis, 17, 1989±1996.
Sharer, J. E. and Wrighton , S. A., 1996, Identi®cation of the human hepatic cytochromes P450
involved in the in vitro oxidation of antipyrine. Drug Metabolism and Disposition, 24, 487±494.
Shimada , T., Yamazaki, H., Mimura , M., Inui , Y. and Guengerich , F. P., 1994, Interindividual
variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs,
carcinogens and toxic chemicals: studies with liver microsomes of 30 japanese and 30 caucasians.
Journal of Pharmacology and Experimental Therapeutics, 270, 414±423.
Smith , D. A. and Jones , B. C., 1992, Speculations on the substrate structure±activity relationship
(
SSAR) of cytochrome P450 enzymes. Biochemical Pharmacology, 44, 2089±2098.
Souhaili -El Amri , H., Batt, A. M. and Siest , G., 1986, Comparison of the cytochrome P-450 content
and activities in liver microsomes for seven animal species, including man. Xenobiotica, 16,
3
51±358.
Tan, Y., White , S. P., Paranawithana , S. R. and Yang, C. S., 1997, A hypothetical model for the
active site of human cytochrome P4502E1. Xenobiotica, 27, 287±301.
Tassaneeyakul , W., Veronese , M. E., Birkett , D. J., Gonzalez, F. J. and Miners , J. O., 1993,
Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA
expression and microsomal kinetic techniques. Biochemical Pharmacology, 46, 1975±1981.
Yun, C.-H., Shimada , T. and Guengerich , F. P., 1991, Puri®cation and characterisation of human liver
microsomal cytochrome P-450 2A6. Molecular Pharmacology, 40, 679±685.